1. Home
  2. DRD vs CDNA Comparison

DRD vs CDNA Comparison

Compare DRD & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DRDGOLD Limited

DRD

DRDGOLD Limited

N/A

Current Price

$24.24

Market Cap

2.5B

ML Signal

N/A

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$66.23

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRD
CDNA
Founded
1895
1998
Country
South Africa
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.6B
IPO Year
2002
2007

Fundamental Metrics

Financial Performance
Metric
DRD
CDNA
Price
$24.24
$66.23
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $58.83
AVG Volume (30 Days)
202.2K
★ 1.0M
Earning Date
10-23-2026
11-03-2026
Dividend Yield
★ 4.28%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 2.13
Revenue
N/A
★ $48,324,000.00
Revenue This Year
$4.20
$30.36
Revenue Next Year
$14.60
$6.23
P/E Ratio
★ $15.32
$30.04
Revenue Growth
N/A
★ 18.93
52 Week Low
$19.47
$13.95
52 Week High
$39.37
$65.50

Technical Indicators

Market Signals
Indicator
DRD
CDNA
Relative Strength Index (RSI) 38.25 78.88
Support Level $19.88 $17.26
Resistance Level $26.30 N/A
Average True Range (ATR) 0.64 2.87
MACD -0.35 0.90
Stochastic Oscillator 0.53 99.39

Price Performance

Historical Comparison
DRD
CDNA

About DRD DRDGOLD Limited

DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: